Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
It copies Glucagon-like peptide 1
Tirzepatide is a medication that belongs to a class of drugs called glucagon-like peptide-1 receptor agonist (GLP-1 RA) and glucagon receptor antagonist (GRA) dual agonists
Proposed mechanisms include enhanced long-term potentiation (a cellular correlate of learning), increased brain-derived neurotrophic factor expression, reduced neuroinflammation, and protection against oxidative stress
May help reduce the risk of autoimmune diseases An autoimmune disorder is a condition in which the body attacks itself
Patient safety advice includes: Report persistent vomiting or signs of dehydration promptly to your healthcare provider Seek urgent medical care for severe abdominal pain, especially if radiating to the back Be aware of symptoms of hypoglycaemia if taking other diabetes medications Inform your doctor if you are planning pregnancy, as GLP-1 receptor agonists should be discontinued (at least 2 months before planned pregnancy for semaglutide) [1] [7] Attend regular follow-up appointments to monitor treatment response and side effects Suspected adverse reactions should be reported via the MHRA Yellow Card Scheme (yellowcard.mhra.gov.uk or via the Yellow Card app)
US$ 22.56
US$ 29.15
US$ 25.19
US$ 23.92
US$ 24.87
US$ 26.91
US$ 22.01
